Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T P Misko

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
Diabetes|February 1, 1993
Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formationR G Tilton, K Chang, K S Hasan, et al.
Journal of Medicinal Chemistry|February 2, 1996
2-Iminopiperidine and other 2-iminoazaheterocycles as potent inhibitors of human nitric oxide synthase isoformsW M Moore, R K Webber, K F Fok, et al.
Journal of Medicinal Chemistry|May 23, 1998
2-Iminohomopiperidinium salts as selective inhibitors of inducible nitric oxide synthase (iNOS)D W Hansen, K B Peterson, M Trivedi, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
Diabetes|February 1, 1993
Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formationR G Tilton, K Chang, K S Hasan, et al.
Journal of Medicinal Chemistry|February 2, 1996
2-Iminopiperidine and other 2-iminoazaheterocycles as potent inhibitors of human nitric oxide synthase isoformsW M Moore, R K Webber, K F Fok, et al.
Journal of Medicinal Chemistry|May 23, 1998
2-Iminohomopiperidinium salts as selective inhibitors of inducible nitric oxide synthase (iNOS)D W Hansen, K B Peterson, M Trivedi, et al.
Pageof 6